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There is concern regarding the teratogenic risks of antiepileptic drugs (AEDs) and the effect of seizures during 
pregnancy. Pre-pregnancy assessment and collaboration with the patient’s neurologist may improve outcome. This 
study examined by postal questionnaire how senior obstetricians in Scotland cared for their patients with epilepsy 
in March 1994. One hundred and nine of 127 (86%) practising obstetricians representative of those working in both 
teaching and district general hospitals in Scotland responded. Only 16% of district general hospital obstetricians 
had an accessible epilepsy clinic/service and 19% a neurologist. Only 21% of all respondents considered that 
pregnancy counselling was being provided by a neurologist/epilepsy specialist, and only 43% were usually able to 
organize combined specialist care with an interested physician/neurologist. Most (79%) were happy with the 
concept of collaborative care. Many were uncertain as to the importance of recording epilepsy severity, genetic 
aspects, making changes to AEDs, monitoring drug levels, the use of vitamin K and breast feeding. Sixty-four per 
cent did not change their management of labour. Twenty per cent were dissatisfied with the present care of their 
patients with epilepsy. Over 90% considered guidelines to be important. This survey demonstrates the need for 
existing epilepsy services to be more accessible to all obstetricians in Scotland, particularly for those working in 
district general hospitals. 
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INTRODUCTION 
Epilepsy is a common medical problem with a 
prevalence of approximately 0.5-l%. Pregnancy 
occurring in women with epilepsy is associated 
with small but significant risks including a 2-3 
fold increase in congential malformation rate’T2. 
Recent guide-lines for the care of pregnant 
women with epilepsy emphasize the need for 
pre-pregnancy assessment and counselling, and 
closer collaboration during pregnancy between 
obstetrician and neurologist or epilepsy 
specialist3.4. 
3 
The purpose of this survey was to examine how 
obstetricians in Scotland currently care for 
pregnant women with epilepsy, and to identify 
specific problems. 
SUBJECTS AND METHODS 
A questionnaire was sent to all senior obste- 
tricians in Scotland in March 1994. The question- 
naires were confidential but coded to allow for a 
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second mailing of non-responders. Questions 
were analysed with respect to the numbers 
responding to each question, and so de- 
nominators vary. 
RESULTS 
One hundred and nine of 127 (86%) senior 
obstetricians (107 consultants and 2 associate 
specialists) currently practising obstetrics in Scot- 
land completed questionnaires. Only 13 were 
female, 77% of whom were aged 45 or less, 
compared with 35% of male obstetricians. There 
was a 100% response from 13 out of the 24 units 
providing in-patient obstetric care, with a >66% 
response from the remainder. Response rates 
were similar for both teaching hospitals and 
district general hospitals. 
Readily available facilities and specialist 
support 
Only 16% of district general hospital obstet- 
ricians had ready access to an epilepsy 
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Table 1: Readily available facilities 
Type of facility All respondents TH respondents DGH respondents 
n = 109 n=47 n = 62 
n (%I n (“/I n (%I 
SBCU/Intensive care cots 106 (97) 41 W) 59 (95) 
Lab monhoring facilities 102 (94) 46 (98) 56 (90) 
Medical intensive care unit/HDU 95 (87) 44 (94) 51 (82) 
High resolution ultrasound scanner 94 (86) 45 (96) 49 (79) 
EEG facilities 64 (59) 38* (81) 26* (41) 
Epilepsy service/clinic 43 (39) 33* (70) 10* (16) 
* Difference between teaching (TH) and district general hospitals (DGH) (x2 test with Yates’ correction): P < 0.01. SBCU. Special 
baby care unit; HDU. high dependency unit. 
service/clinic compared with 70% in teaching 
hospital units. EEG facilities were also less 
available in district general hospitals (Table 1). 
Only 19% of district general hospital obstet- 
ricians considered a neurologist to be readily 
available to them compared with 80% from 
teaching hospitals (Table 2). While all teaching 
hospital obstetricians had ready access to either a 
neurologist, interested physician/clinical phar- 
macologist and/or an epilepsy service/clinic, only 
37% working in district general hospitals had 
similar access. Fifty-one percent (56/109) were 
unaware of specialist pre-pregnancy counselling 
being locally available for their patients with 
epilepsy, 73% were from district general hospi- 
tals. Of those who considered pre-pregnancy 
counselling to be available, 42% (22/52) provided 
this service entirely on their own with no other 
support. Only 25% (13/52) considered that a 
neurologist was providing this service and 44% 
(23/52) a neurologist or interested physician. All 
19% who considered that a clinical geneticist was 
available for pre-pregnancy counselling came 
from teaching hospital units. 
Attitudes to specific concerns regarding epi- 
lepsy and pre-pregnancy care are summarized in 
Table 3. Only 55% felt that it was important to 
consider withdrawal of AED treatment if seizure 
free for more than two years. Thirty-nine per cent 
felt that the risk of epilepsy developing in the 
offspring was not usually important, although this 
is a common anxiety of women themselves. 
Care during pregnancy and labour 
Fifty-four per cent (58/108) of respondents saw 
less than five patients a year with epilepsy and 
29% (31/108) between six and ten. Twenty-six 
percent (27/103) rarely/never involved a neurol- 
ogist or any physician in the care of their patients 
with epilepsy-74% (20/27) were from district 
general hospitals. Forty-three per cent usually 
and 31% sometimes involved a neurologist/ 
Table 2: Readily available specialist medical support and supporting services 
All respondents TH respondents 
n = 108 n=46 
n (%I n (%I 
DGH respondents 





79 (73) 26 (57) 54 (87) 
49 (45) 37* (80) 12: (19) 
29 (27) 25* (54) 4* (6) 
Interested physician 28 (26) 16 (35) 12 (19) 
Neurologist/interested physician 66 (61) 45* (98) 21* (34) 
Paediatrician 97 (90) 42 (91) 55 (89) 
Psychiatrist 55 (51) 26 (57) 29 (47) 
Clinical geneticist 51 (47) 32* (70) 19* (31) 
Social worker 75 (69) 31 (67) 44 (71) 
Family planning clinic 61 (56) 27 (59) 34 (55) 
Clinical nurse specialist in epilepsy 4 (4) 3 (7) 1 (2) 
Other-midwife with special interest 2 (2) 1 (2) 1 (2) 
Epilepsy Association worker 1 (Cl) 1 (2) 0 (0) 
Specialist pre-pregnancy counselling 53 (49) 36* (77)** 17* (27) 
* Difference between teaching (TH) and district general hospitals (DGH) k2 test with Yates’ correction): P < 0.01. ** 47 teaching 
hospital obstetricians responded to this question. 
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Table 3: Attitudes to specific concerns regarding epilepsy and pre-pregnancy care; responses to: 
Which of the following do you regard as important considerations before pregnancy occurs? 
Considered to be always/usually important No. 
(i) specialist assessment of the patient’s epilepsy? 85/106 
(ii) review of antiepileptic drug treatment? 103/108 
(iii) withdrawal of antiepileptic treatment if seizure free >2 years? 55/100 






(v) a background family history of congenital malformation? 721103 (70) 
How important do you think it is for you to ensure that mothers with epilepsy have an understanding of the following? 
Considered to be always/usually important 
(i) the risk to the foetus from material seizures occuring in pregnancy? 
(ii) the possibility of seizure pattern changing in pregnancy? 
(iii) the risk of antiepileptic drugs to the developing foetus? 
(iv) the risk of epilepsy developing in offspring? 
(v) the need for compliance if remaining on antiepileptic medication? 







physician. Only nine would refer or see patients 
in combined medical-obstetric clinics. Of the 56 
providing details of how combined care was 
organized, 91% copied correspondence to each 
other, and 80% sometimes telephoned to discuss 
patients. Seventy-nine per cent (77/98) were very 
happy with the concept of involving a 
neurologist/physician in the care of their preg- 
nant patients with epilepsy. 
Attitudes to specific concerns regarding epi- 
lepsy and antiepileptic drug therapy in pregnancy 
are summarized in Table 4. Around 20% did not 
consider a description of the patient’s typical 
seizures or a history of injury during seizures to 
be important despite falls and injuries being of 
particular concern in pregnancy. Thirty-five per 
cent would not usually monitor serum AED 
levels during pregnancy and 50% did not adjust 
AED treatment themselves. Thirteen per cent 
would always/usually discourage breast-feeding. 
Sixty-four per cent (68/106) rarely/never al- 
tered their management of labour. The following 
procedures were more likely to differ from usual 
practice: intravenous access 32/62 (52%), con- 
tinuous foetal monitoring 19/61 (31%), assisted 
delivery (excluding Caesarean section) 12/60 
Table 4: Attitudes to specific concerns regarding epilepsy and pregnancy care; responses to: 
Which of the following details do you consider important to record/know about as part of your management of your pregnant patients 
with epilepsy? 
Considered to be always/usually important Response No. (%I 
(i) clear confirmation of the diagnosis, e.g. history of witnessed seizures 92/105 038) 
(ii) duration of epilepsy 781104 (75) 
(iii) history of serial seizures/status 95/101 (94) 
(iv) description of patient’s typical seizures 831103 (81) 
(v) seizure frequency 101/104 (97) 
(vi) date of last seizure 991104 (95) 
(vii) factors influencing epilepsy control 94/104 (90) 
(viii) history of injury during seizures 821103 (80) 
If your patient is taking antiepileptic drugs; do you 
(i) stress the importance of compliance? 
(ii) monitor serum antiepileptic drug levels? 
(iii) adjust antiepileptic treatment yourself? 
(iv) offer prenatal screening? 
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(20%), induction of labour 7/62 (ll%), and 
Caesarean section 4162 (6%). 
Use of vitamin K 
Fifty-six per cent (51/88) never gave pregnant 
women with epilepsy vitamin K, while 24% 
always/usually and 18% sometimes did. Only 
seven obstetricians were able to give details of 
how they gave vitamin K to mothers with 
epilepsy; responses varied, specifying lo- 
20 mg/day given orally from 36 or 38 weeks of the 
pregnancy. 
Eighty-six percent (78/91) always/usually gave 
vitamin K to the newborn of mothers with 
epilepsy, but 5% never gave vitamin K (all were 
from district general hospitals). Of the 42 who 
were able to give some details; 31 gave it by 
intramuscular injection, four by intramuscular 
injection after operative delivery or depending on 
the AED used, and seven orally. 
Satisfaction with current practice 
Only 16% (17/106) were very satisfied with the 
present level of care received by their patients 
with epilepsy, while 20% were dissatisfied, four of 
whom were very dissatisfied. Obstetricians were 
more likely to be satisfied if they worked in a 
teaching hospital, had an epilepsy service or 
readily available neurologist/interested physi- 
cian, if pre-pregnancy counselling was available, 
and if they were able to combine care with a 
neurologist/physician. Forty-three per cent 
(44/103) thought it was important for one 
obstetrician in their unit or health board area to 
have special responsibility for pregnant patients 
with epilepsy, but 48% did not agree. Over 90% 
(98/108) considered guidelines to be important. 
Forty-one per cent felt this was very important. 
Invited comments made by 43% of the 
obstetricians at the end of the questionnaire are 
summarized in Table 5. 
DISCUSSION 
This is a unique national study of the pregnancy 
care of women with epilepsy, representing the 
views of the majority of senior obstetricians 
throughout Scotland. 
One of the most striking findings is the 
discrepancy in the ready availability of neurology 
and specialist epilepsy services between obstet- 
ricians working in district general hospitals, who 
are responsible for 60% of all deliveries in 
Scotland, and those in teaching hospitals. In 
comparison, it is likely that most hospitals will 
Table 5: Examples of comments made at the end of the 
questionnaire 
“our neurologists are too busy to see all pregnant epileptics” 
“neurologists could be made more aware of the problems of 
pregnancy-they are in a better position to advise on 
pre-pregnancy care” 
“the opportunity for pre-pregnancy counselling is often 
missed. . .” 
“a protocol for all.. . lack of systematic approach to these 
patients” 
“one obstetrician. . . not workable in large rural practice” 
“patients are usually seen at booking with no previous 
pre-pregnancy care and no folate supplements having been 
given” 
“there is poor awareness of the problem.. .” 
“more input from interested physician/neurologist” 
“a joint clinic would be useful” 
“specialist neurological involvement or general physician in 
complicated epilepsy is invaluable” 
‘& . . GP role is crucial both preconception and during 
pregnancy” 
11 . . . we have had two babies here with severe 
abnormalities. . . .” 
“I regard the GP as the key player. . .” 
have readily available physicians with an interest 
in diabetes (which has a similar prevalence to that 
of epilepsy) who are able to collaborate closely 
with obstetric colleagues. It has been almost 12 
years since Espir and Hytten urged neurologists 
and obstetricians to collaborate and provide such 
care5. 
Pre-pregnancy care 
Pregnancy occurring in women with epilepsy is 
high risk. There is a 2-3 times higher risk of 
major congenital malformation’,2, 30% risk of 
more seizures6, and there may be an increased 
risk of complications during pregnancy’*2. Spe- 
cialist assessment of the seizure disorder, with 
withdrawal of unnecessary AEDs and adjustment 
of ongoing treatment to appropriate monothe- 
rapy and low dosage appears to reduce the risk of 
AED induced malformation and adverse 
outcome’.‘. Folate supplements taken preconcep- 
tually may lessen the risk of neural tube defect”. 
This risk is increased with sodium valproate 
(l-2%)10 and proabably carbamazepine (OS- 
1 %)Y Women with epilepsy require counsell- 
ing regarding the risks of major anomalies and the 
more common minor dysmorphic changes3, and 
specific genetic advice including their genetic 
predisposition to antiepileptic drug induced 
teratogenesis . I3 Planning a pregnancy requires 
informed contraceptive advice, e.g. enzyme- 
inducing AEDs can reduce the efficacy of the 
combined oestrogen-progesterone pi1114. Epi- 
lepsy care in pregnancy needs to begin before 
pregnancy occurs. 
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Many of the obstetricians responding to the 
questionnaire stressed the importance of pre- 
pregnancy care and the need for neurologists and 
interested physicians to be more involved. Prena- 
tal screening was also considered important, but 
20% of district hospital obstetricians did not have 
a readily available high resolution ultra-sound 
scanner, which can detect 94% of neural tube 
defects.” 
Organization of care during pregnancy and 
labour 
Fifty-four per cent of obstetricians saw fewer than 
five patients a year with epilepsy (expected 
average approximately 2-3 per year). With such 
small numbers it is difficult to gain a great deal of 
expertise in managing patients with epilepsy-a 
good case for involving specialist help during 
pregnancy and for one obsetrician in each locality 
to develop a special interest. Forty-three per cent 
felt the latter to be important but not always 
practicable. Although only 43% usually involved 
a neurologist/physician; 79% were happy with 
the idea, i.e. they would if they could. Most 
thought that the specific concerns referred to in 
Table 4 were important, although many did not 
adjust AED treatment themselves or normally 
monitor serum antiepileptic drug levels during 
pregnancy, a useful check for compliance, toxicity 
and guide to dosage adjustment. Free drug levels 
are more important clinically’6. 
Few obstetricians held combined medical- 
obstetric clinics, and the most usual method of 
involving another specialist was to copy corres- 
pondence to each other. Obstetricians have 
pioneered the use of shared care cards and 
patient held medical records for routine ante- 
natal care. The latter may be an ideal method of 
co-ordinating care where combined clinics are not 
possible or practical. Specialist epilepsy nurses 
and midwives appear to be an underused resource 
to help co-ordinate care. 
That many obstetricians did not change their 
management of labour is in accordance with 
experience elsewhere”. There is probably little 
justification in inducing labour or for 
assisted/operative delivery in uncomplicated la- 
bour, and it may be the anxious unsupported 
obstetrician who is most likely to intervene. 
Vitamin K 
The neonate is deficient in vitamin K, and lack of 
supplementation at birth can result in haemor- 
rhagic disease of the newborn”. This risk is 
increased further in babies whose mothers are 
taking enzyme inducing AEDs, with bleeding 
occurring early and with significant mortality. 
Prevalence in this group may be as high as 10%‘“. 
Currently there is controversy as to whether the 
more protective method of intramuscular vitamin 
K supplementation is safe’8’20. It has been 
recommended that pregnant women with epi- 
lepsy are given 20 mg vitamin K orally during the 
last four weeks of pregnancy, but there is no clear 
concensus, and evidence of benefit is largely 
anecdota12’. There is though clear consensus that 
all infants should receive adequate vitamin K 
supplementation following delivery, although 
recent guidelines advise the use of oral rather 
than IM vitamin K4.“‘. There was much uncer- 
tainty regarding the use of maternal vitamin K in 
our questionnaire, with 56% bf responding 
obstetricians never giving vitamin K in pre- 
gnancy. This is perhaps not surprising in view of 
the current uncertainty regarding its 
effectiveness. It is of particular concern that the 
use of neonatal vitamin K was not universally 
recommended. A few commented that the 
decision to give neonatal vitamin K was the 
concern of the paediatrician, so these results may 
not therefore reflect current practice, although 
they seem similar to UK practice ascertained by 
questionnaire in 19882”. Further studies regarding 
the safety and effectiveness of vitamin K are 
required. 
Role of the paediatrician 
Good perinatal care should be available for the 
infants of mothers with epilepsy. Apart from the 
risk of congential abnormalities, a 2-3 fold 
increased risk of perinatal death, increased risk of 
prematurity and low birth weight have been 
reported . ‘.’ There may also be a higher than 
average risk of developmental delay and learning 
difficulties24. Paediatricians developing local pro- 
tocols for neonatal vitamin K, need to consider 
women on AEDs. Breast feeding issues also 
commonly involve the paediatrician. 
It is of concern that 10% of obstetricians did 
not consider that a paediatrician was readily 
available to them, and 5% of district general 
hospital obstetricians did not have ready access to 
a special baby care unit or to intensive care cots. 
It is also very disappointing that so many 
obstetricians still discourage women with epilepsy 
from breast feeding as contraindications are 
few25. 
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Table 6: Guidelines-a framework to consider when 
developing guidelines to optimize the care of pregnant 
women with epilepsy 
Informed contraceptive advice 
for all women with epilepsy of childbearing age 
Pre-pregnancy 
assessment by epilepsy specialist 
review of diagnosis 
review of antiepileptic drug treatment 
counselling-and genetic counselling if indicated 
folate supplements prior to conception 
Pregnancy 
detailed ultrasound scanning in second trimester 
regular review with close liaison between epilepsy specialist 
and obstetrician 
monitoring of antiepileptic drug levels at intervals 
Post partum 
Vitamin K to neonate at birth 
breastfeeding rarely contraindicated 
support and advice for parents, e.g. minimising risk to baby 
from maternal seizures 
provision of effective contraception 
SUMMARY 
We present the responses of 109 practising 
obstetricians, representing 86% of those working 
in both teaching and district general hospitals in 
Scotland to a questionnaire on the current care of 
their patients with epilepsy. Our main findings are 
that considerable discrepancies exist in the 
availability of neurology and specialist epilepsy 
services for obstetricians in district general 
hospitals compared with those from teaching 
units. 
Areas of uncertainty amongst all the obstet- 
ricians included the importance of recording 
epilepsy severity, genetic aspects, making changes 
to AEDs, monitoring drug levels, use of vitamin 
K and recommending breast feeding. Many 
respondents stressed the importance of pre- 
pregnancy care and the need for neurologists and 
interested physicians to be more involved and 
over 90% considered the development of guide- 
lines to be important. A framework for develop- 
ing guidelines is outlined in Table 6. 
CONCLUSION 
To ensure that all women with epilepsy can 
receive optimal pre-pregnancy care and com- 
bined specialist care during pregnancy, there is a 
clear need for improved specialist epilepsy 
services especially in district general hospitals. 
Neurologists, interested physicians and general 
practitioners should discuss with obstetricians 
A.J.C. Russell et al 
existing guidelines, adapting them to suit local 
needs. 
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